Aurinia Pharmaceuticals (AUPH) FCF Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,728.00 |
| Dec 31, 2025 | -128.00 |
| Sep 30, 2025 | -264.00 |
| Jun 30, 2025 | 6,100.00 |
| Mar 31, 2025 | -4,815.00 |
| Dec 31, 2024 | 2,521.00 |
| Sep 30, 2024 | -248.00 |
| Jun 30, 2024 | 6,447.00 |
| Mar 31, 2024 | -6,807.00 |
| Dec 31, 2023 | 5,524.00 |
| Sep 30, 2023 | -1,692.00 |
| Jun 30, 2023 | 8,581.00 |
| Mar 31, 2023 | -12,933.00 |
| Dec 31, 2022 | 6,389.00 |
| Sep 30, 2022 | 7,139.00 |
| Jun 30, 2022 | 11,753.00 |
| Mar 31, 2022 | -10,960.00 |
| Dec 31, 2021 | 19,135.00 |
| Sep 30, 2021 | 32,828.00 |
| Jun 30, 2021 | 534,498.00 |
| Mar 31, 2021 | -598,279.00 |
| Dec 31, 2020 | 9.32 Mn |
| Sep 30, 2020 | -9.35 Mn |
| Sep 30, 2015 | 13,769.00 |